Skip to main content
OpenTrials

Clinical trial condition

Nodal Marginal Zone B-cell Lymphoma

Explore clinical trials studying Nodal Marginal Zone B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

83 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Nodal Marginal Zone B-cell Lymphoma trial results

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mercy Medical Center Canton, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States
View Trial Details

Related conditions